Live Breaking News & Updates on Combination Induction Therapy
Stay updated with breaking news from Combination induction therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Results of Novel Clinical Study of Guselkumab and Golimumab Combination Therapy Show Adults with Moderately to Severely Active Ulcerative Colitis Maintained Higher Rates of Clinical, Histologic, and E streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The rate of clinical remission was 47.9 percent in patients who received combination induction therapy with guselkumab and golimumab compared with either treatment alone at 38 weeks1
SPRING HOUSE, Pa., Feb. 19, 2022 /PRNewswire/ The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from a Phase 2a clinical trial that showed the combination of ....